SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, invites investors to listen to an online webcast of its latest investor conference call in which Dr. Stephen Chang, Chief Executive Officer of MultiCell, discussed the Company’s lead therapeutics programs in addition to recent events and progress.
